BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Career Advice

  How to Continually Invest in Your Career

  Think of your career as a living, breathing thing. In order to keep it alive, you need to continually feed it so it can thrive. But how do you do that?

  August 21, 2019

   · 

  2 min read

   · 

  Laura Brothers
• 

  Drug Development

  AstraZeneca’s Imfinzi Combination Treatment Misses the OS Mark in Metastatic Lung Cancer

  The Phase III NEPTUNE trial assessed the combination treatment as a first-line treatment in an “all-comers population,” with the primary analysis population being patients with a high tumor mutational burden.

  August 21, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Oncorus Raised $79.5 Million Series B to Take Cancer-Killing Virus Program into the Clinic

  The round was co-led by Cowen Healthcare Investments and Perceptive Advisors.

  August 21, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Why the FDA Dropped the Hammer on Novartis Data Manipulation Scandal

  Some have wondered why the agency has hit back at Novartis so hard when the data in question didn’t have any effect on the eventual outcomes of the product’s effectiveness and safety.

  August 21, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Teva’s CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial

  Over a 12-week course of treatment, Teva said fremanezumab provided patients with statistically significant reductions in monthly average number of migraine days. The results of the study were published in Lancet.

  August 21, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  BioSpace Global Roundup, Aug. 22

  Companies from across the globe provide updates on their business and pipelines.

  August 21, 2019

   · 

  6 min read

   · 

  Alex Keown
• Machine learning models help clinicians identify people who need advanced depression care

  Researchers at Regenstrief Institute and Indiana University created decision models capable of predicting which patients might need more treatment for their depression than what their primary care provider can offer.

  August 21, 2019

   · 

  3 min read
• Drug Development

  MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy

  MyoKardia, Inc. announced that it has dosed the first subjects in a Phase 1 clinical study of MYK-224, a small molecule candidate being developed for the treatment of hypertrophic cardiomyopathy.

  August 21, 2019

   · 

  6 min read
• 

  Business

  Pfizer Investing $500 Million in North Carolina Gene Therapy Facility, Adding 300 Jobs

  “This investment will further strengthen Pfizer’s leadership in gene therapy manufacturing technology,” stated Mike McDermott, president, Pfizer Global Supply.

  August 21, 2019

   · 

  3 min read

   · 

  Mark Terry
• Job Trends

  Fannin Awarded $1 Million NIH Grant For Continued Development of Asthma Drug

  The National Institutes of Health has awarded Fannin Innovation Studio® a $1 million grant to continue development of PM-43I, the company’s anti-asthma drug, in collaboration with portfolio company Atrapos Therapeutics, LLC., as a more effective alternative to steroids.

  August 21, 2019

   · 

  3 min read